29
Gerald S. Bloomfield, MD, MPH DGHI, Division of Cardiology, Duke University September 2013 Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities

Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities

  • Upload
    padma

  • View
    49

  • Download
    0

Embed Size (px)

DESCRIPTION

Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities. Gerald S. Bloomfield, MD, MPH DGHI, Division of Cardiology, Duke University September 2013. Outline. Trends in selected NCDs in LMICs Epidemiologic transition Data challenges Approaches to NCD research in LMICs. - PowerPoint PPT Presentation

Citation preview

Page 1: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Gerald S. Bloomfield, MD, MPH

DGHI,Division of Cardiology,Duke University

September 2013

Non-Communicable Diseases in LMICs:

Myths, Facts and Opportunities

Page 2: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Trends in selected NCDs in LMICsEpidemiologic transitionData challengesApproaches to NCD research in LMICs

OUTLINE

Page 3: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

CARDIOVASCULAR DISEASE

Page 4: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Common CVDs: Rheumatic, infectious, pericardial, high BP

Heart failure is endemic in SSA Dilated cardiomyopathy: 48% of admissions Causes: RHD, Hypertension, Peripartum, Idiopathic

Coronary heart disease “distinctly rare”Diagnostic limitations

Lack of specialized investigations Viral, nutritional, familial, alcohol, immune, ischemia

68% of ‘idiopathic’ can be mislabeled

CLASSIC TEACHING ON CARDIOVASCULAR DISEASES IN SSA

RHD = Rheumatic Heart Disease Watkins and Mayosi. Cardiovascular Journal of Africa 2009BP = blood pressure Oyoo and Ogola. East African medical journal 1999

Mokhobo. S Afr Med J 1980

Page 5: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

“Africans are immune to heart/coronary disease”

Ancient Egypt1370 BC

Heavy Heart is a Bad Heart

Kenya.2 years, 1800 patients. 0% HTN, arteriosclerosis

Uganda.2 years0% HTN

Kalahari San. No increase in BP with age

No change in BP with age

Prev. HTN

Ghana 13% Nigeria 25% Lesotho 7%

History of chronic CVD in Africa

1920s 1941 1960 1970s

1976-81901

Uganda. N= 1500“High tension pulses not often met with”

1958-72: 8-11% admissions due to CVD

1980-90s

40% hospital admissions with any CVD

2010:CVD is the 2nd most common cause of death in SSA

Page 6: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

325 migrants, 267 controls followed for 24 months

SBP changes over 24 months

LUO MIGRATION STUDY

Poulter BMJ 1990

Page 7: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

PULMONARY DISEASE

Page 8: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

DEATHS DUE TO PULMONARY DISEASE

Develo

ped 1

990

Develo

ped 2

010

Develo

ping 1

990

Develo

ping 2

010

0500000

100000015000002000000250000030000003500000

ILDPneumoconiosesAsthmaCOPD

www.healthmetricsandevaluation.org 2013

Page 9: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Adult Smoking Prevalence, 2009

Youth Smoking Prevalence, 2009

Tobacco Control Report from the Region of the Americas 2011

Page 10: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

http://www.who.int/tobacco/en/atlas19.pdf

Page 11: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

PROPORTION OF PATIENTS WITH COPD WHO ARE NON-SMOKERS

USA

Colombia

Brazil

Chile

Mexico

Urugua

y

Vene

zuela

0%

20%

40%

60%

80%

100%

Salvi and Barnes. Lancet 2009

Page 12: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

www.who.int/ceh/publications/en/map09b.jpg

Page 13: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

85% of all global particulate exposure occurs indoors

HAP levels are typically higher than developed world standards for ambient air quality

EPA Standard: 150 micrograms/cubed meter Households with HAP:

300-3000 During cooking 30,000 50x more carbon

monoxide

HOUSEHOLD AIR POLLUTION

HAP in Nigeriahttp://magazine.uchicago.edu/1102/investigations/indoor_air_pollution.shtml

Page 14: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

DIABETES AND HIGH BLOOD SUGAR

Page 15: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Health Statistics and Informatics

Leading causes of attributable global mortality and burden of disease, 2004

%

1. High blood pressure 12.8

2. Tobacco use8.7

3. High blood glucose 5.8

4. Physical inactivity 5.5

5. Overweight and obesity 4.8

6. High cholesterol 4.5

7. Unsafe sex 4.0

8. Alcohol use3.8

9. Childhood underweight 3.8

10. Indoor smoke from solid fuels 3.3

59 million total global deaths in 2004

%

1. Childhood underweight 5.9

2. Unsafe sex4.6

3. Alcohol use4.5

4. Unsafe water, sanitation, hygiene 4.2

5. High blood pressure3.7

6. Tobacco use3.7

7. Suboptimal breastfeeding 2.9

8. High blood glucose 2.7

9. Indoor smoke from solid fuels 2.7

10. Overweight and obesity 2.3

1.5 billion total global DALYs in 2004

Attributable Mortality Attributable DALYs

Page 16: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

EPICENTERS OF DIABETES

Deaths from diabetes

Page 17: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Hu. Diabetes Care 2011

Page 18: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

The Epidemiologic TransitionDescription Life

Expectancy% deaths from CV

Dominant CVDs

Stage 1 Pestilence and Famine

•Malnutrition•Infectious diseases

35 years <10 •Infectious (RHD)•Nutritional

Stage 2 Receding pandemics

•Improved nutrition and public health•Chronic disease•Hypertension

50 years 10-35 •Infectious (RHD)•Stroke-haemorrhagic

Stage 3 Degenerative and man-made diseases

•High fat and caloric intake•Tobacco use•Chronic diseases > infectious, malnutrition

>60 years 35-65 •Ischemic heart disease (IHD)•Stroke – haemorrhagic, ischaemic

Stage 4 Delayed degenerative diseases

•Leading causes of mortality CV and cancer deaths•Prevention and treatment delays onset•Age-adjusted CV death reduced

>70 years 40-50 •IHD•Stroke – ischaemic•CHF

From Gersh et al. European Heart Journal 2010

Page 19: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

THE PERFECT STORM OF CVD IN LMICS

Gersh et al. EHJ 2010LMICs: low- and middle-income countries

Page 20: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Development Diet

Tobacco

Sedentary lifestyle

Technology

Urbanization

Industry

Page 21: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Projected Deaths by Cause

Beaglehole and Bonita. Lancet 2008

Page 22: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

WHERE DO WE GO FROM HERE?

Page 23: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

1980-87 1987-94 1994-2000

2000-080%

10%20%30%40%50%60%70%80%90%

100%

West AfricaSouthern AfricaEast AfricaNigeriaSouth Africa

PERCENT OF CVD STUDIES FROM SSA BY COUNTRY/REGION, 1980-2008

Page 24: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

CONTEMPORARY CAUSES OF HEART FAILURE IN SSA

Bloomfield et al. Curr Cardiol Reviews 2013

Page 25: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

“FLTR” FOR NCDS

FindLinkTreatRetain

HOSPITAL

HOSPITAL

Health Center

Dispensary

COMMUNITY

COMMUNITY

Current scenario

Proposed scenario

Optimizing Linkage and Retention to Hypertension Care in Kenya: LARK Hypertension Study. Slide courtesy of R. Vedanthan, Mt. Sinai

Page 26: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

OPTIMIZING LINKAGE AND RETENTIONTO HYPERTENSION CARE:

LARK HYPERTENSION

Page 27: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Oxford Health Alliance 2006

AN OPPORTUNITY FOR PRIMARY PREVENTION

Page 28: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

THE GOOD NEWS: PREVENTION WORKS

http://www.ktl.fi

Page 29: Non-Communicable  Diseases  in  LMICs:  Myths, Facts and Opportunities

Non-Communicable Diseases in LMICs: Myths, Facts and Opportunities

Gerald S. Bloomfield, MD, MPHDuke Global Health Institute

Division of CardiologyDuke University

THANK YOU